Goldman Revives Healthcare Firm’s Loan Sale After Struggle (1)

A group of banks led by Goldman Sachs Group Inc. has resumed efforts to sell debt for healthcare services firm Sevitaafter scrapping an offering in October — one of several leveraged loan sales that have struggled to attract demand in recent weeks.

The banks are marketing an $875 million, five-year loan paying 5.25 to 5.5 percentage points above the benchmark, at a discounted price of 97 cents on the dollar, according to a person with knowledge of the matter. The loan financing also includes a $375 million delayed draw term loan, said the person.

Sevita scrapped a $2.5 billion ...